Introduction Real-world data on current treatment practices for non–small-cell lung cancer
(NSCLC) are needed to understand the place in therapy and potential economic impact of …

Purpose This study sought to better understand real-world treatment patterns, overall and
non–small-cell lung cancer (NSCLC)-specific survival, adverse event (AE) occurrence, and …

While results from clinical trials are important in determining the efficacy of treatment,
restrictive eligibility criteria may limit generalizability to patient populations in the real-world …

Background Knowledge of the real-world treatment patterns for non–small-cell lung cancer
(NSCLC) can identify quality-of-care gaps and guide resource allocation needs. Our …

Objectives This retrospective study used the US Oncology iKnowMed™ database, billing
claims, and chart reviews to report treatment patterns and outcomes in late-stage non-small …

Simple Summary The aim of this study was to evaluate treatment patterns and real-world
clinical outcomes since immunotherapy was introduced in Japan as the initial (first-line) …

Aim: To identify contemporary first-and second-line treatment patterns for advanced non-
small-cell lung cancer (aNSCLC) and associated costs. Methods: This study identified …

Most patients with advanced non-small cell lung cancer (NSCLC) have a poor prognosis
and receive limited benefit from conventional treatments, especially in later lines of therapy …

Purpose Treatments for advanced non-small cell lung cancer (NSCLC) have evolved to
include targeted and immuno-oncology therapies, which have demonstrated clinical benefits …

PURPOSE: We conducted a cross-sectional survey of practicing medical oncologists in the
United States to obtain insight into physician and patient treatment decision making in stage …